Results 101 to 110 of about 15,940 (198)

A Comprehensive Review of Modern Cancer Therapies Utilizing Oncolytic Viruses. [PDF]

Cells
Sułek M, Szuster-Ciesielska A.
europepmc   +1 more source

Viral warriors: Unlocking the immune system's potential with oncolytic viruses in cancer immunotherapy. [PDF]

Mol Ther Oncol
Ghavimi R, Rahimian L, Mohammadi M, Dutta O, Mohan H, Chouljenko V, Omolekan TO, Chamcheu JC, Kousoulas KG.   +8 more
europepmc   +1 more source

Oncolytic viruses: A novel therapeutic approach for pancreatic cancer. [PDF]

Mol Ther Oncol
Esteves M, Matos AM, Cruz MT.
europepmc   +1 more source

Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic Directions. [PDF]

Cancers (Basel)
Liu J, Wang Y, Su S, Cheng G, Zhao H, Sun J, Sun G, Li F, Hui R, Liu M, Wu L, Wu D, Yang F, Dang Y, Hei J, Li Y, Gao Z, Wang B, Bai Y, Lv W, Zhang J.   +20 more
europepmc   +1 more source

Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy. [PDF]

Curr Issues Mol Biol
Zhang C, Sun Q.
europepmc   +1 more source

Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses. [PDF]

Front Immunol
Omolekan TO, Folahan JT, Tesfay MZ, Mohan H, Dutta O, Rahimian L, Ferdous KU, Ghavimi R, Cios A, Beng TK, Francis J, D'Auvergne O, Borad MJ, Kousoulas KG, DiGiuseppe S, Nagalo BM, Chamcheu JC.   +16 more
europepmc   +1 more source

Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review). [PDF]

Int J Oncol
Bi S, Shan T, Tang Y, Wang Q.
europepmc   +1 more source

Design and Efficacy of Oncolytic Viruses and Antitumor Vaccines: A Dead End in the Immunotherapy of Pancreatic Cancer? [PDF]

Int J Mol Sci
Achim E, Pîrlici E, Cristea C, Tertis M.   +3 more
europepmc   +1 more source

Oncolytic viruses targeting CD47: a new road to success? [PDF]

J Immunother Cancer
Takimoto CH, Wick MJ.
europepmc   +1 more source

Next-Generation Oncolytic Viruses to Overcome Resistance to Anti-PD-1 Therapy in Melanoma. [PDF]

J Clin Oncol
McArthur GA.
europepmc   +1 more source